Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.

Eur J Heart Fail · 2010 · PMC2844760 · PMID 20335355

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

showed a trendP = 0.066so close (0.05 < p ≤ 0.1)

At 24 h, the mean improvement in cardiac index from baseline showed a trend in favour of levosimendan over dobutamine (M-W P = 0.066).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.